Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;25(9):1083-1093.
doi: 10.1007/s11886-023-01925-3. Epub 2023 Jul 31.

Update on Transcatheter Device Closure of Congenital Septal Defects

Kathleen P Wood  1 , Gregory A Fleming  1 , Reid C Chamberlain  2
Affiliations
Review

Update on Transcatheter Device Closure of Congenital Septal Defects

Kathleen P Wood et al. Curr Cardiol Rep. 2023 Sep.

Abstract

Purpose of review: The goal of this paper is to review currently available devices for closure of atrial septal defects (ASDs) and ventricular septal defects (VSDs).

Recent findings: Favorable results from the ASSURED trial resulted in FDA approval for the most recently developed device for transcatheter ASD closure in the United States. Further studies are required to assist in the development or approval of safe devices for transcatheter perimembranous VSD closure in pediatric patients. Device closure is the less invasive and preferred management option for many ASDs, with multiple studies demonstrating lower complication rates, shorter hospital stays, and lower mortality than surgical repair. Complex ASDs that make device closure more difficult include large defects, rim deficiencies, fenestrated defects, multiple defects, and the presence of pulmonary arterial hypertension. Device closure has also become an accepted alternative to surgery for some types of ventricular septal defects VSDs, though challenges and limitations remain. Future innovations including novel devices and techniques are needed to further expand on the types of defects that can be safely closed via transcatheter approach.

Keywords: Atrial septal defect; Device closure; Transcatheter intervention; Ventricular septal defect.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance
    1. Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD. Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455–63. https://doi.org/10.1093/ije/dyz009 . PMID: 30783674; PMCID: PMC6469300. - DOI - PubMed - PMC
    1. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation. 2006;114(15):1645–53. https://doi.org/10.1161/CIRCULATIONAHA.105.592055 . PMID: 17030704. - DOI - PubMed
    1. Mills NL, King TD. Nonoperative closure of left-to-right shunts. J Thorac Cardiovasc Surg. 1976;72(3):371–8. PMID: 134183. - DOI - PubMed
    1. Villablanca PA, Briston DA, Rodés-Cabau J, Briceno DF, Rao G, Aljoudi M, et al. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int J Cardiol. 2017;15(241):149–55. https://doi.org/10.1016/j.ijcard.2017.03.073 . Epub 2017 Mar 24 PMID: 28390741. - DOI
    1. Turner DR, Owada CY, Sang CJ Jr, Khan M, Lim DS. Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study. Circ Cardiovasc Interv. 2017;10(8):e004212. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004212 . PMID: 28801537; PMCID: PMC5559192.

LinkOut - more resources